145 related articles for article (PubMed ID: 17334533)
1. A double-blind comparison of the effect of the antipsychotics haloperidol and olanzapine on sleep in mania.
Moreno RA; Hanna MM; Tavares SM; Wang YP
Braz J Med Biol Res; 2007 Mar; 40(3):357-66. PubMed ID: 17334533
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
[TBL] [Abstract][Full Text] [Related]
3. Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.
Berk M; Ng F; Wang WV; Tohen M; Lubman DI; Vieta E; Dodd S
J Affect Disord; 2008 Sep; 110(1-2):126-34. PubMed ID: 18280579
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
Perlis RH; Baker RW; Zarate CA; Brown EB; Schuh LM; Jamal HH; Tohen M
J Clin Psychiatry; 2006 Nov; 67(11):1747-53. PubMed ID: 17196055
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
J Affect Disord; 2012 Feb; 136(3):476-84. PubMed ID: 22134043
[TBL] [Abstract][Full Text] [Related]
7. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
[TBL] [Abstract][Full Text] [Related]
8. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.
Tohen M; Goldberg JF; Gonzalez-Pinto Arrillaga AM; Azorin JM; Vieta E; Hardy-Bayle MC; Lawson WB; Emsley RA; Zhang F; Baker RW; Risser RC; Namjoshi MA; Evans AR; Breier A
Arch Gen Psychiatry; 2003 Dec; 60(12):1218-26. PubMed ID: 14662554
[TBL] [Abstract][Full Text] [Related]
9. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
Keck PE; Corya SA; Altshuler LL; Ketter TA; McElroy SL; Case M; Briggs SD; Tohen M
J Clin Psychiatry; 2005 May; 66(5):611-6. PubMed ID: 15889948
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.
Tohen M; Jacobs TG; Grundy SL; McElroy SL; Banov MC; Janicak PG; Sanger T; Risser R; Zhang F; Toma V; Francis J; Tollefson GD; Breier A
Arch Gen Psychiatry; 2000 Sep; 57(9):841-9. PubMed ID: 10986547
[TBL] [Abstract][Full Text] [Related]
11. Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program.
Szegedi A; Zhao J; McIntyre RS
J Affect Disord; 2013 Sep; 150(3):745-52. PubMed ID: 23473546
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial.
Berk M; Ichim L; Brook S
Int Clin Psychopharmacol; 1999 Nov; 14(6):339-43. PubMed ID: 10565800
[TBL] [Abstract][Full Text] [Related]
15. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
[TBL] [Abstract][Full Text] [Related]
16. Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials.
Cavazzoni PA; Berg PH; Kryzhanovskaya LA; Briggs SD; Roddy TE; Tohen M; Kane JM
J Clin Psychiatry; 2006 Jan; 67(1):107-13. PubMed ID: 16426096
[TBL] [Abstract][Full Text] [Related]
17. Have antipsychotics a different speed of action in the acute treatment of mania? A single-blind comparative study.
Buoli M; Esposito CM; Godio M; Caldiroli A; Serati M; Altamura AC
J Psychopharmacol; 2017 Dec; 31(12):1537-1543. PubMed ID: 28462607
[TBL] [Abstract][Full Text] [Related]
18. Acute phase results from STORM, a multicountry observational study of bipolar disorder treatment and outcomes.
Treuer T; Oruc L; Loza N; El Saidi MA; Kovacs Z; Akkaya C; Gülseren S; Saylan M; Colman SA; Harrison GA
Psychiatr Danub; 2007 Dec; 19(4):282-95. PubMed ID: 18000479
[TBL] [Abstract][Full Text] [Related]
19. A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial.
Berk M; Brook S; Trandafir AI
Int Clin Psychopharmacol; 1999 May; 14(3):177-80. PubMed ID: 10435771
[TBL] [Abstract][Full Text] [Related]
20. Sleep architecture and cognitive changes in olanzapine-treated patients with depression: a double blind randomized placebo controlled trial.
Lazowski LK; Townsend B; Hawken ER; Jokic R; du Toit R; Milev R
BMC Psychiatry; 2014 Jul; 14():202. PubMed ID: 25030264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
